eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
3/2024
vol. 26
 
Share:
Send email
Share:
Review paper

Neurodegenerative diseases and color vision impairment: a literature review

Eva Mrázková
1
,
Nikol Gottfriedová
2
,
Martina Kovalová
1, 2, 3
,
Ondřej Machaczka
1, 3
,
Veronika Koutná
4
,
Vladimír Janout
1
,
Jana Janoutová
1, 4

  1. Center for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Czech Republic
  2. Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Czech Republic
  3. Department of Healthcare Management and Public Health, Faculty of Health Sciences, Palacký University Olomouc, Czech Republic
  4. Department of Public Health, Faculty of Medicine and Dentistry, Palacký University Olomouc, Czech Republic
Family Medicine & Primary Care Review 2024; 26(3): 389–401
DOI: https://doi.org/10.5114/fmpcr.2024.142014
Online publish date: 2024/09/30
Article file
- 15 FM&PCR 3 24 - R - Mrazkova - 1583 - Neurodegenerative diseases.pdf  [0.58 MB]
Get citation
 
PlumX metrics:
 
1. Gauthier S, Rosa-Neto P, Morais JA, et al. World Alzheimer Report 2021: Journey through the diagnosis of dementia. Alzheimer Disease International, McGill University, 2021 Sep 21. Available from URL: https://www.alzint.org/resource/world-alzheimer-report-2021/.
2. DeKosky ST, Marek K. Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders. Science 2003; 302(5646): 830–834, doi: 10.1126/science.1090349.
3. Prince M, Wimo A, Guerchet M, et al. World Alzheimer Report 2015. The Global Impact of Dementia: An Analysis of prevalence, Incidence, cost and Trends. Alzheimer’s Disease International, McGill University. 2015 Sep 21. Available from URL: https://www.alzint.org/resource/world-alzheimer-report-2015/.
4. Stites SD, Harkins K, Rubright JD, et al. Relationships Between Cognitive Complaints and Quality of Life in Older Adults with Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition. Alzheimer Dis Assoc Disord 2018; 32(4): 276–283, doi: 10.1097/WAD.0000000000000262.
5. Cacioppo JT, Hawkley LC. Perceived social isolation and cognition. Trends Cognitive Sci 2009; 13(10): 447–454, doi: 10.1016/j.tics.2009.06.005.
6. Rasmussen J, Langerman H. Alzheimer’s Disease – Why We Need Early Diagnosis. Degener Neurol Neuromuscul Dis 2019; 9: 123–130, doi: 10.2147/DNND.S228939.
7. Turner RS, Stubbs T, Davies DA, et al. Potential New Approaches for Diagnosis of Alzheimer’s Disease and Related Dementias. Front Neurol 2020; 11, doi: 10.3389/fneur.2020.00496.
8. Blennow K, Zetterberg H. Biomarkers for alzheimer’s disease: Current status and prospects for the future. J Int Med 2018; 284(6): 643–663, doi: 10.1111/joim.12816.
9. Kim HJ, Ryou JH, Choi KT, et al. Deficits in color detection in patients with Alzheimer disease. PLoS ONE 2022; 17(1): e0262226, doi: 10.1371/journal.pone.0262226.
10. Postuma RB, Gagnon J-F, Vendette M, et al. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011; 69(5): 811–818, doi: 10.1002/ana.22282.
11. Simunovic MP. Acquired color vision deficiency. Surv Ophthalmol 2016; 61(2): 132–155, doi: 10.1016/j.survophthal.2015.11.004.
12. Staden D, Van, Noor Mahomed F, Govender S, et al. Comparing the validity of an online Ishihara colour vision test to the traditional Ishihara handbook in a South African university population. AVEH 2018; 77(1), doi: 10.4102/aveh.v77i1.370.
13. Birch J. Worldwide prevalence of red-green color deficiency. J Opt Soc Am A Opt Image Sci Vis 2012; 29(3): 313–320, doi: 10.1364/JOSAA.29.000313.
14. Purves D, Augustine GJ, Fitzpatrick D, et al. Neuroscience. 2nd ed. Sunderland (MA): Sinauer Associates; 2001.
15. Archibald NK, Clarke MP, Mosimann UP, et al. The retina in Parkinson’s disease. Brain 2009; 132(5): 1128–1145, doi: 10.1093/brain/awp068.
16. Archibald NK, Clarke MP, Mosimann UP, et al. Retinal thickness in Parkinson’s disease. Parkinsonism & Related Disorders 2011; 17(6): 431–436, doi: 10.1016/j.parkreldis.2011.03.004.
17. Wang L, Mao X. Role of Retinal Amyloid-β in Neurodegenerative Diseases: Overlapping Mechanisms and Emerging Clinical Applications. Int J Mol Sci 2021; 22(5), doi: 10.3390/ijms22052360.
18. Postuma RB, Gagnon JF, Vendette M, et al. Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson’s disease. Brain 2009; 132(12): 3298–3307, doi: 10.1093/brain/awp244.
19. Stanzani Maserati M, Mitolo M, Medici F, et al. Color Choice Preference in Cognitively Impaired Patients: A Look Inside Alzheimer’s Disease Through the Use of Lüscher Color Diagnostic. Front Psychol 2019; 10, doi: 10.3389/fpsyg.2019.01951.
20. Gretton C, Ffytche DH. Art and the brain: a view from dementia. Int J Geriatr Psychiatry 2013; 29(2): 111–126, doi: 10.1002/gps.3975.
21. Ostermann T, Robens S, Heymann P, et al. Analysis of the Use of Colour for Early Detection of Dementia. In: Proceedings of the 13th International Joint Conference on Biomedical Engineering Systems and Technologies, doi: 10.5220/0008881303160320.
22. Pita R, Aretouli E, Loukopoulou E, et al. Can “Football-Team Color-Code” Compensate for Anomia? The case study of FN, a patient with color anomia. Neurocase 2005; 11(3): 227–233, doi: 10.1080/13554790590944870.
23. Takeda S, Tajime K, Taniguchi T. The Takeda Three Colors Combination Test: A Screening Test for Detection of Very Mild Alzheimer’s Disease. Scientific World Journal 2014; 2014: 1–5, doi: 10.1155/2014/907316.
24. Uttl B, Graf P. Color-Word Stroop test performance across the adult life span. J Clin Exp Neuropsychol 1997; 19(3): 405–420, doi: 10.1080/01688639708403869.
25. Kvitting AS, Wimo A, Johansson MM, et al. A Quick Test of Cognitive Speed (AQT): Usefulness in dementia evaluations in primary care. Scand J Prim Health Care 2013; 31(1): 13–19, doi: 10.3109/02813432.2012.751699.
26. Pache M. Colour vision deficiencies in Alzheimer’s disease. Age Ageing 2003; 32(4): 422–426, doi: 10.1093/ageing/32.4.422.
27. Salobrar-Garcia E, de Hoz R, Rojas B, et al. Ophthalmologic Psychophysical Tests Support OCT Findings in Mild Alzheimer’s Disease. J Ophthalmol 2015; 2015: 1–10, doi: 10.1155/2015/736949.
28. Cronin-Golomb A, Corkin S, Rizzo JF, et al. Visual dysfunction in Alzheimer’s disease: Relation to normal aging. Ann Neurol 1991; 29(1): 41–52, doi: 10.1002/ana.410290110.
29. Kurylo DD, Corkin S, Dolan RP, et al. Broad-band visual capacities are not selectively impaired in Alzheimer’s disease. Neurobiol Aging 1994; 15(3): 305–311, doi: 10.1016/0197-4580(94)90025-6.
30. Wijk H, Berg S, Sivik L, et al. Colour discrimination, colour naming and colour preferences among individuals with Alzheimer’s disease. Int J Geriatr Psychiatry 1999; 14(12): 1000–1005.
31. Birch J. Efficiency of the Ishihara test for identifying red-green colour deficiency. Ophthalmic Physiol Opt 1997; 17(5): 403–408.
32. Unger RH, Flanigan PM, Khosravi M, et al. Clinical and Imaging Characteristics Associated with Color Vision Impairment in Lewy Body Disease. J Alzheimers Dis 2019; 72(4): 1233–1240, doi: 10.3233/JAD-190727.
33. Bertrand J-A, Bedetti C, Postuma RB, et al. Color discrimination deficits in Parkinson’s disease are related to cognitive impairment and white-matter alterations. Mov Disord 2012; 27(14): 1781–1788, doi: 10.1002/mds.25272.
34. Salamone G, Lorenzo C, Mosti S, et al. Color Discrimination Performance in Patients with Alzheimer’s Disease. Dement Geriatr Cogn Disord 2009; 27(6): 501–517, doi: 10.1159/000218366.
35. Arnaoutoglou NA, Arnaoutoglou M, Nemtsas P, et al. Color perception differentiates Alzheimer’s Disease (AD) from Vascular Dementia (VaD) patients. Int Psychogeriatr 2017; 29(8): 1355–1361, doi: 10.1017/S1041610217000096.
36. Flanigan PM, Khosravi MA, Leverenz JB, et al. Color Vision Impairment Differentiates Alzheimer Dementia from Dementia with Lewy Bodies. J Geriatr Psychiatry Neurol 2018; 31(2): 97–102, doi: 10.1177/0891988718767579.
37. Sen S, Saxena R, Vibha D, et al. Detection of structural and electrical disturbances in macula and optic nerve in Alzheimer’s patients and their correlation with disease severity. Semin Ophthalmol 2020; 35(2): 116–125, doi: 10.1080/08820538.2020.1748203.
38. Oishi Y, Imamura T, Shimomura T, et al. Vegetable Freshness Perception in Dementia with Lewy Bodies and Alzheimer’s Disease. Dement Geriatr Cogn Dis Extra 2020; 10(2): 74–85, doi: 10.1159/000508282.
39. Oishi Y, Imamura T, Shimomura T, et al. Visual texture agnosia in dementia with Lewy bodies and Alzheimer’s disease. Cortex 2018; 103: 277–290, doi: 10.1016/j.cortex.2018.03.018.
40. Salobrar-García E, de Hoz R, Ramírez AI, et al. Changes in visual function and retinal structure in the progression of Alzheimer’s disease. PLoS ONE 2019; 14(8): e0220535, doi: 10.1371/journal.pone.0220535.
41. Matar E, Phillips JR, Martens KAE, et al. Impaired Color Discrimination – A Specific Marker of Hallucinations in Lewy Body Disorders. J Geriatr Psychiatry Neurol 2019; 32(5): 257–264, doi: 10.1177/0891988719845501.
42. Polo V, Rodrigo MJ, Garcia-Martin E, et al. Visual dysfunction and its correlation with retinal changes in patients with Alzheimer’s disease. Eye 2017; 31(7): 1034–1041, doi: 10.1038/eye.2017.23.
43. Kersten HM, Danesh-Meyer HV, Kilfoyle DH, et al. Optical coherence tomography findings in Huntington’s disease: a potential biomarker of disease progression. J Neurol 2015; 262(11): 2457–2465, doi: 10.1007/s00415-015-7869-2.
44. Anang JBM, Gagnon J-F, Bertrand J-A, et al. Predictors of dementia in Parkinson disease. Neurology 2014; 83(14): 1253–1260, doi: 10.1212/WNL.0000000000000842.
45. Sun L, Zhang H, Gu Z, et al. Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson’s disease. Eur J Med Res 2014; 19(1): 29, doi: 10.1186/2047-783X-19-29.
46. Cernin PA, Keller BK, Stoner JA. Color Vision in Alzheimer’s Patients: Can We Improve Object Recognition with Color Cues? Aging, Neuropsychology, and Cognition 2003; 10(4): 255–267, doi: 10.1076/anec.10.4.255.28971.
47. Rizzo M, Anderson SW, Dawson J, et al. Vision and cognition in Alzheimer’s disease. Neuropsychologia 2000; 38(8): 1157–1169, doi: 10.1016/S0028-3932(00)00023-3.
48. Rogers TT, Graham KS, Patterson K. Semantic impairment disrupts perception, memory, and naming of secondary but not primary colours. Neuropsychologia 2015; 70: 296–308, doi: 10.1016/j.neuropsychologia.2015.01.010.
49. Rogers TT, Patterson K, Graham K. Colour knowledge in semantic dementia: It is not all black and white. Neuropsychologia 2007; 45(14): 3285–3298, doi: 10.1016/j.neuropsychologia.2007.06.020.
50. Wood JS, Firbank MJ, Mosimann UP, et al. Testing Visual Perception in Dementia with Lewy Bodies and Alzheimer Disease. Am J Geriatr Psychiatry 2013; 21(6): 501–508, doi: 10.1016/j.jagp.2012.11.015.
51. Lehmann M, Barnes J, Ridgway GR, et al. Basic Visual Function and Cortical Thickness Patterns in Posterior Cortical Atrophy. Cereb Cortex 2011; 21(9): 2122–2132, doi: 10.1093/cercor/bhq287.
52. Wijk H, Berg S, Bergman B, et al. Colour perception among the very elderly related to visual and cognitive function. Scand J Caring Sci 2002; 16(1): 91–102, doi: 10.1046/j.1471-6712.2002.00063.x.
53. World Health Organization. Launch of WHO’s Parkinson disease technical brief. 14 June 2022 [cited 07.08.2023]. Available from URL: https://www.who.int/news/item/14-06-2022-launch-of-who-s-parkinson-disease-technical-brief.
54. Myrberg K, Hydén L-C, Samuelsson C. The mini-mental state examination (MMSE) from a language perspective: an analysis of test interaction. Clin Linguist Phon 2020; 34(7): 652–670, doi: 10.1080/02699206.2019.1687757.
55. Davis D, Creavin ST, Yip JL, et al. Montreal Cognitive Assessment for the detection of dementia. Cochrane Database Syst Rev 2021; 2021(7): CD010775, doi: 10.1002/14651858.CD010775.pub3.
56. Payne M, Manera V, Robert P, et al. Olfactory identification disorders due to Alzheimer’s disease: A new test from France to Quebec. PLoS ONE 2022; 17(4): e0265764, doi: 10.1371/journal.pone.0265764.
57. Campabadal A, Uribe C, Segura B, et al. Brain correlates of progressive olfactory loss in Parkinson›s disease. Parkinsonism & Related Disorders 2017; 41: 44–50, doi: 10.1016/j.parkreldis.2017.05.005.
58. Roberts RO, Christianson TJH, Kremers WK, et al. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia. JAMA Neurology 2016; 73(1): 93–101, doi: 10.1001/jamaneurol.2015.2952.
59. Kovalová M, Gottfriedová N, Mrázková E, et al. Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review. Otolaryngol Pol 2024; 78(2), doi: 10.5604/01.3001.0053.6158.
60. Pekel NB, Yildiz D, Taymur I, et al. Associations Between Olfactory Impairment and Cognitive Functions in Patients with Parkinson Disease. Noro Psikiyatr Ars 2019; 57(3): 216–221, doi: 10.29399/npa.23070.
61. Marigliano V, Gualdi G, Servello A, et al. Olfactory Deficit and Hippocampal Volume Loss for Early Diagnosis of Alzheimer Disease: a pilot study. Alzheimer Dis Assoc Disord 2014; 28(2): 194–197, doi: 10.1097/WAD.0b013e31827bdb9f.
62. Chan D. A disorder of colour perception associated with abnormal colour after-images: a defect of the primary visual cortex. J Neurol Neurosurg Psychiatry 2001; 71(4): 515–517, doi: 10.1136/jnnp.71.4.515.
Copyright: © 2024 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.